Ask AI
Bill117th CongressFiled May 5, 2022Health
S. 4152

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary introduced in senate (May 5, 2022)

This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.

What just happenedMay 5, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Sen. Kelly, Mark [D-AZ](D-AZ)Sponsor
2 cosponsors1 D1 R
Read on Congress.gov
2cosponsors1committees2actions3related bills
  1. May 5, 2022IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. May 5, 2022IntroReferral10000

    Introduced in Senate

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path … — Informed